Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lu Zhang
Observed name:
Zhang, Lu
Institution:
First Affiliated Hospital of Xi'an Jiaotong University
Observed institutions:
Shanghai Jiao Tong University,
Renji Hospital,
Shanghai Cancer Institute,
First Affiliated Hospital of Xi'an Jiaotong University,
CanSino (China),
Xi'an Jiaotong University
show all 6
ORCID:
0000-0003-2137-2893
Observed ORCID:
0000-0003-2137-2893
OpenAlex ID:
A5101905191
Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2023
·
Ruiyun Zhang
, Jingyu Zang
, et al.
·
Clinical Cancer Research
·
39
Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer
2024
·
Lu Zhang
, Ruiyun Zhang
, et al.
·
British Journal of Cancer
·
37
PDF
Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
·
Clinical Cancer Research
·
11
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial
2024
·
Xu Han
, Mingwei Wei
, et al.
·
Vaccines
·
2
Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2025
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Figure S1-S6 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2025
·
Ruiyun Zhang
, Jingyu Zang
, et al.
PDF
Supplementary Information 1 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
2025
·
Ruiyun Zhang
, Jingyu Zang
, et al.
PDF
Supplementary Figure S1 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
PDF
Supplementary Figure S8 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
PDF
Supplementary Figure S5 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
Supplementary Figure S2 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
Supplementary Figure S3 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
PDF
Supplementary Table S1-S10 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
Supplementary Figure S9 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
PDF
Supplementary Figure S4 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
Supplementary Figure S10 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
PDF
Supplementary Figure S7 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
PDF
Data from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
Supplementary Figure S6 from Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer
2024
·
Jingyu Zang
, Akezhouli Shahatiaili
, et al.
Table S1-S8 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Figure S1-S6 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Supplementary Information 1 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Figure S1-S6 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Supplementary Information 1 from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
PDF
Data from Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer
2024
·
Ruiyun Zhang
, Jingyu Zang
, et al.
Show more works
View as search
Works count:
39
Citation count:
89
H-index:
3
I10-index:
3
Year
Topic
Type